Literature DB >> 24591673

Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient.

Aniek J Raamsteeboers1, Harm Jan Bogaard, Anton Vonk Noordegraaf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24591673     DOI： 10.1183/09059180.00005513

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN： 0905-9180


× No keyword cloud information.
  2 in total

1.  Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis.

Authors:  Andrew J Bryant; Linda J Robinson; Christy S Moore; Thomas R Blackwell; Santhi Gladson; Niki L Penner; Ankita Burman; Lucas J McClellan; Vasiliy V Polosukhin; Harikrishna Tanjore; Melinda E McConaha; Linda A Gleaves; Megha A Talati; Anna R Hemnes; Joshua P Fessel; William E Lawson; Timothy S Blackwell; James D West
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

2.  Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension.

Authors:  Ning-Yuan Chen; Scott D Collum; Fayong Luo; Tingting Weng; Thuy-Trahn Le; Adriana M Hernandez; Kemly Philip; Jose G Molina; Luis J Garcia-Morales; Yanna Cao; Tien C Ko; Javier Amione-Guerra; Odeaa Al-Jabbari; Raquel R Bunge; Keith Youker; Brian A Bruckner; Rizwan Hamid; Jonathan Davies; Neeraj Sinha; Harry Karmouty-Quintana
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-17       Impact factor: 5.464
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.